ArthroFree Wireless Camera System for Minimally Invasive Surgery Receives FDA Market Clearance

Lazurite today announced that its ArthroFree™ System is now the first and only wireless camera system for minimally invasive surgery to receive U.S. Food and Drug Administration (FDA) market clearance.

The ArthroFree™ System incorporates the company’s proprietary low-heat, high-intensity Meridiem™ light technology along with advanced camera, battery, and wireless transmission technologies. It is designed to deliver improved operating room productivity, patient safety, and economic value through cost-savings, energy efficiency, and reduced setup/breakdown times. The modular system also is designed to be drop-in compatible with patient data consoles, surgical displays and endoscopes found in minimally invasive operating rooms.
Visit the Lazurite  CONTACT PAGE to request a demonstration/trial use or to purchase the ArthroFree™ System, which has received notable interest and accolades from prominent surgeons.
“I’ve had the opportunity to use the ArthroFree camera in the laboratory, and I’m absolutely amazed at the quality of the picture and the way the device feels in my hands,” said Mark Schickendantz, M.D., director of the Center for Sports Health at the Cleveland Clinic and since 1992 team physician for the Cleveland Guardians baseball team. “What’s incredible is to be able to use an arthroscope that doesn’t have the cumbersome cables. That is just absolutely incredible.”
“With ArthroFree, you have excellent quality images and simultaneously you have a clean, streamlined, uncluttered surgical field. It’s all built into the camera. When you pick it up and pop in the battery, it’s on. In a few years, I think, this is going to be the standard,” said University Hospitals Health System trauma surgeon Jeffrey Ustin, M.D.
“The ArthroFree™ System provides freedom of movement we’ve never had before,” said  Laith Jazrawi, M.D., Chief of Sports Medicine at NYU Langone Orthopedic Hospital. “You don’t have to move cables around. The camera is lightweight and easy to handle. I can’t imagine a surgeon who wouldn’t want this.”
Eugene Malinskiy, Chief Executive Officer and cofounder of Lazurite, emphasized the company’s commitment to creating high value innovation in partnership with the medical community. “The idea for what is now the FDA-cleared ArthroFree System was born from the very real need to create a safer, more efficient operating room for the benefit of everyone involved—from patients to surgeons to OR teams to clinics and hospitals.”
Malinskiy and his team believe “that this truly is the beginning of the operating room of the future. The entire endoscopic market will benefit from our minimally invasive surgical equipment advancement going forward.”
Mark Froimson, M.D., Chair of the Board of Lazurite elaborated, “We are proud to have achieved this major milestone on our way to bringing operating rooms across the country into the wireless age. In the coming year, we will be introducing the ArthroFree System to thousands of healthcare professionals at conferences, in demos, through distributors and group purchasing channels, and through partnerships with leading medical centers.”
Physicians and other healthcare professionals are encouraged to experience pre-production demo models of the ArthroFree System at a range of upcoming medical conferences this year:
  • American Academy of Orthopaedic Surgeons (AAOS), March 22-26 in Chicago (Booth 2305)
  • Ambulatory Surgery Center Association (ASCA), April 27-30 in Dallas (Booth 424)
  • Arthroscopy Association of North America (AANA) May 19-21 in San Francisco
  • American Orthopaedic Society for Sports Medicine (AOSSM), July 13-18 in Colorado Springs
  • American College of Surgeons (ACS), October 16-18 in San Diego
Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


The recent FDA clearances included Brainomix 360 e-CTP and Brainomix 360 e-MRI, both software modules that can support thrombolysis and thrombectomy treatment decisions, particularly for late-window patients who present to hospital more than 6-12 hours after stroke onset.
IONIC Health’s 510(k)-pending nCommand Lite technology is designed to include vendor-agnostic remote scanning capabilities. This strategic collaboration’s goal is to enable GE HealthCare to provide a multi-vendor, multi-modality remote scanning solution to healthcare systems and patients around the globe.
Silmitasertib works by inhibiting CK2 protein kinase, which have implicated in regulation of several signaling pathways that are important for innate immune responses. CK2 modulates inflammatory pathways, including NF-κB, PI3K–Akt–mTOR, and JAK–STAT.
"This is the culmination of years of research and development to deliver a medical device that helps improve the lives of patients suffering from spinal stenosis. Our recent move to larger premises in the Research Park at FAU will allow us to train our surgical and distribution partners to become increasingly competitive in the spinal implant device market,” said Peter Harris, founder and CEO of FloSpine.
Anticipated to be the first CDH17 CAR T cell therapy to enter the clinic. Phase 1A clinical trial to initiate patient enrolment in 2024. Phase 1A clinical trial will enroll patients with advanced Colorectal Cancer, Gastric Cancer and Neuroendocrine Tumours.

By using this website you agree to accept Medical Device News Magazine Privacy Policy